Ireland vs Marshall Islands: The number of people with susceptibility test result for rifampicin
Ireland
40
in 2021
Marshall Islands
31
in 2021
Ireland rank
125th
Marshall Islands rank
127th
The number of people with susceptibility test result for rifampicin over time
- Ireland
- Marshall Islands
How they compare
Ireland currently reports 40 against 31 in Marshall Islands, a difference of 9.
That makes Ireland's figure about 1.3 times Marshall Islands's.
Across all 5 years both countries report, Ireland has been ahead every year.
Ireland ranks 125th and Marshall Islands ranks 127th of 155 countries.
Ireland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ireland | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95 | 54 | 41 | Ireland |
| 2020s | 53 | 25.5 | 27.5 | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Ireland or Marshall Islands?
- Ireland, at 40 against 31 in Marshall Islands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Ireland and Marshall Islands?
- 9, with Ireland ahead.
- How many years of comparable data are there for Ireland and Marshall Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Ireland and Marshall Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Ireland ranks 125th and Marshall Islands ranks 127th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.